MaxCyte, Inc. (MXCT) Tops Q1 EPS by 4c May 12, 2026 04:49PM
MaxCyte Inc. (MXCT) PT Lowered to $4 at Stifel Mar 25, 2026 10:04AM
MaxCyte Inc. (MXCT) PT Lowered to $5 at Craig-Hallum Mar 25, 2026 10:00AM
MaxCyte, Inc. (MXCT) Misses Q4 EPS by 1c Mar 24, 2026 04:29PM
William Blair on MaxCyte Inc. (MXCT): CFO appointment 'not all that needle-moving' Mar 23, 2026 09:50AM


Sep 22, 2025 04:31PM MaxCyte to cut 34% of workforce in restructuring to reach profitability
Aug 11, 2025 04:33PM MaxCyte, Inc. (MXCT) Announces Departure of Chief Commercial Officer
Aug 11, 2025 06:06AM BTIG Downgrades MaxCyte Inc. (MXCT) to Neutral
Aug 7, 2025 04:02AM William Blair Downgrades MaxCyte Inc. (MXCT) to Market Perform
Aug 6, 2025 06:40PM MaxCyte, Inc. (MXCT) Misses Q2 EPS by 2c
May 8, 2025 05:47AM MaxCyte Inc. (MXCT) PT Lowered to $5 at BTIG
May 7, 2025 04:54PM MaxCyte, Inc. (MXCT) Tops Q1 EPS by 1c
Mar 12, 2025 09:17AM MaxCyte Inc. (MXCT) PT Lowered to $9 at Stifel
Mar 12, 2025 05:29AM MaxCyte Inc. (MXCT) PT Lowered to $6 at BTIG
Mar 11, 2025 05:14PM MaxCyte, Inc. (MXCT) Tops Q4 EPS by 2c
Nov 6, 2024 05:05PM MaxCyte, Inc. (MXCT) Tops Q3 EPS by 1c
Oct 15, 2024 08:05AM Poseida Therapeutics (PSTX) Appoints Cynthia Collins to its Board
Sep 24, 2024 08:38AM TD Cowen Reiterates Buy Rating on MaxCyte Inc. (MXCT)